Cantor Fitzgerald Maintains Overweight on TerrAscend, Raises Price Target to $7.9
Cantor Fitzgerald analyst Pablo Zuanic maintains TerrAscend (OTC:TRSSF) with a Overweight and raises the price target from $7.65 to $7.9.
Cannabis Stock Movers For March 15, 2022
GAINERS:
Rhinomed (OTC:RHNMF) shares closed up 35.71% at $0.19
Why Federal Cannabis Legalization Is ‘A Question Of When, Not If,’ Says Canopy Growth CEO: Meet Our Keynote Speakers
"The pessimist complains about the wind. The optimist expects it to change. The leader adjusts the sails.” John Maxwell
Another Cannabis Delivery App Lands On Apple Store: TerrAscend’s The Apothecarium App Available In New Jersey & California
TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has launched The Apothecarium mobile retail app for Apple iOS devices.
Pharmacist Managing Billion Dollar Cannabis-Focused Fund, Jason Wild Of TerrAscend: Meet Our Keynote Speakers
It is well known that a career is a lifelong journey that can take many turns. Today we're taking a look at an inspiring story of a pharmacist who ended up managing a multi-billion fund focused on cannabis and healthcare.
TerrAscend To Close $545M Acquisition Of Gage Cannabis On March 10th
TerrAscend Corp. (OTCQX: TRSSF) (CSE:TER) and Gage Growth Corp.
Cannabis Stock Gainers And Losers From March 7, 2022
GAINERS:
Nine Energy Service (NYSE:NINE) shares closed up 100.00% at $3.60
Cannabis Movers & Shakers: Acreage, Harborside, Item 9, Halo Collective, TerrAscend, Flora Growth, PathogenDx
BioTech Co. PathogenDx Strengthens Executive Team
Biotechnology company, PathogenDx has bolstered its strategic advisory group and senior leadership team with the appointments of several highly experienced executives who will bring their expertise to the company.
The new leadership appointments include:
